Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Autoimmune Disorders

  Free Subscription


22.07.2019

1 Acta Neurol Scand
1 Ann Neurol
2 BMC Neurol
2 Brain
3 Diabet Med
1 Diabetes
3 J Autoimmun
1 J Immunol
3 J Neurol
1 J Rheumatol
2 Lancet Neurol
2 Mult Scler
1 N Engl J Med
2 Neurology
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
    Real-life use of oral disease-modifying treatments in Austria.
    Acta Neurol Scand. 2019;140:32-39.
    PubMed     Text format     Abstract available


    Ann Neurol

  2. JUREK B, Chayka M, Kreye J, Lang K, et al
    Human gestational NMDAR autoantibodies impair neonatal murine brain function.
    Ann Neurol. 2019 Jul 20. doi: 10.1002/ana.25552.
    PubMed     Text format     Abstract available


    BMC Neurol

  3. BANSBACK N, Chiu JA, Carruthers R, Metcalfe R, et al
    Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients.
    BMC Neurol. 2019;19:173.
    PubMed     Text format     Abstract available

  4. CHOU CC, Su IC, Chou IJ, Lin JJ, et al
    Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
    BMC Neurol. 2019;19:170.
    PubMed     Text format     Abstract available


    Brain

  5. HAUSLER D, Torke S, Peelen E, Bertsch T, et al
    High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium.
    Brain. 2019 Jul 13. pii: 5532100. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. WENTLING M, Lopez-Gomez C, Park HJ, Amatruda M, et al
    A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis.
    Brain. 2019 Jul 15. pii: 5531715. doi: 10.1093.
    PubMed     Text format     Abstract available


    Diabet Med

  7. HAUFFE F, Schaefer-Graf UM, Fauzan R, Schohe AL, et al
    Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection.
    Diabet Med. 2019;36:158-166.
    PubMed     Text format     Abstract available

  8. SAMII L, Kallas-Koeman M, Donovan LE, Lodha A, et al
    The association between vascular complications during pregnancy in women with Type 1 diabetes and congenital malformations.
    Diabet Med. 2018 Nov 30. doi: 10.1111/dme.13872.
    PubMed     Text format     Abstract available

  9. ALVARO-AFONSO FJ, Lazaro-Martinez JL, Garcia-Morales E, Garcia-Alvarez Y, et al
    Cortical disruption is the most reliable and accurate plain radiographic sign in the diagnosis of diabetic foot osteomyelitis.
    Diabet Med. 2018 Sep 23. doi: 10.1111/dme.13824.
    PubMed     Text format     Abstract available


    Diabetes

  10. KALLIONPAA H, Somani J, Tuomela S, Ullah U, et al
    Early Detection of Peripheral Blood Cell Signature in Children Developing Beta-Cell Autoimmunity at a Young Age.
    Diabetes. 2019 Jul 16. pii: db19-0287. doi: 10.2337/db19-0287.
    PubMed     Text format     Abstract available


    J Autoimmun

  11. PACHECO Y, Acosta-Ampudia Y, Monsalve DM, Chang C, et al
    Bystander activation and autoimmunity.
    J Autoimmun. 2019 Jul 17:102301. doi: 10.1016/j.jaut.2019.
    PubMed     Text format     Abstract available

  12. MEIER HCS, Parks CG, Liu HB, Sandler DP, et al
    Cellular aging over 13 years associated with incident antinuclear antibody positivity in the Baltimore Longitudinal Study of Aging.
    J Autoimmun. 2019 Jul 11. pii: S0896-8411(19)30210.
    PubMed     Text format     Abstract available

  13. SHIN JI, Lee KH, Joo YH, Lee JM, et al
    Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
    J Autoimmun. 2019 Jul 17:102299. doi: 10.1016/j.jaut.2019.
    PubMed     Text format     Abstract available


    J Immunol

  14. AKIYAMA C, Tsumiyama K, Uchimura C, Honda E, et al
    Conditional Upregulation of IFN-alpha Alone Is Sufficient to Induce Systemic Lupus Erythematosus.
    J Immunol. 2019 Jul 19. pii: jimmunol.1801617. doi: 10.4049/jimmunol.1801617.
    PubMed     Text format     Abstract available


    J Neurol

  15. MO XB, Lei SF, Qian QY, Guo YF, et al
    Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis.
    J Neurol. 2019 Jul 18. pii: 10.1007/s00415-019-09476.
    PubMed     Text format     Abstract available

  16. MICHAEL G, Christian E, Fritz L, Jorg K, et al
    Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
    J Neurol. 2019 Jul 16. pii: 10.1007/s00415-019-09464.
    PubMed     Text format     Abstract available

  17. RAIMO S, Trojano L, Gaita M, Spitaleri D, et al
    High openness and high extroversion are linked with better time-based prospective memory in multiple sclerosis.
    J Neurol. 2019 Jul 16. pii: 10.1007/s00415-019-09460.
    PubMed     Text format     Abstract available


    J Rheumatol

  18. BREKKE LK, Fevang BS, Diamantopoulos AP, Assmus J, et al
    Risk of cancer in 767 patients with giant cell arteritis in western Norway: a retrospective cohort with matched controls.
    J Rheumatol. 2019 Jul 15. pii: jrheum.190147. doi: 10.3899/jrheum.190147.
    PubMed     Text format     Abstract available


    Lancet Neurol

  19. PLOUGHMAN M
    Restoring function in progressive multiple sclerosis.
    Lancet Neurol. 2019;18:711-712.
    PubMed     Text format    

  20. FREEMAN J, Hendrie W, Jarrett L, Hawton A, et al
    Assessment of a home-based standing frame programme in people with progressive multiple sclerosis (SUMS): a pragmatic, multi-centre, randomised, controlled trial and cost-effectiveness analysis.
    Lancet Neurol. 2019;18:736-747.
    PubMed     Text format     Abstract available


    Mult Scler

  21. HACOHEN Y, Brownlee W, Mankad K, Chong WK', et al
    Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children in a real-life cohort.
    Mult Scler. 2019 Jul 18:1352458519863781. doi: 10.1177/1352458519863781.
    PubMed     Text format     Abstract available

  22. CAMARA-LEMARROY CR, Silva C, Greenfield J, Liu WQ, et al
    Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity.
    Mult Scler. 2019 Jul 18:1352458519863133. doi: 10.1177/1352458519863133.
    PubMed     Text format     Abstract available


    N Engl J Med

  23. CHEN Z, Wang X, Ye S
    Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease.
    N Engl J Med. 2019;381:291-293.
    PubMed     Text format    


    Neurology

  24. TITULAER MJ, Irani SR, Lassmann H
    PDE10A antibodies in autoimmune encephalitis: A possible marker of cancer immunotherapy?
    Neurology. 2019 Jul 17. pii: WNL.0000000000007965.
    PubMed     Text format    

  25. ZEKERIDOU A, Kryzer T, Guo Y, Hassan A, et al
    Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity.
    Neurology. 2019 Jul 17. pii: WNL.0000000000007971.
    PubMed     Text format     Abstract available


    Thyroid

  26. AZIZI F, Amouzegar A, Tohidi M, Hedayati M, et al
    Increased remission rates after long-term methimazole therapy in patients with Graves' disease: Results of a randomized clinical trial.
    Thyroid. 2019 Jul 16. doi: 10.1089/thy.2019.0180.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: